NervGen Pharma Corp.

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, NONOF has a market cap of 214.8B. Regarding current trading prices, NGENF is priced at $4.29, while NONOF trades at $40.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas NONOF's P/E ratio is 13.21. In terms of profitability, NGENF's ROE is -974.60%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, NGENF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check NONOF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CSLLY has a market cap of 104.7B. Regarding current trading prices, NGENF is priced at $4.29, while CSLLY trades at $52.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CSLLY's P/E ratio is 17.56. In terms of profitability, NGENF's ROE is -974.60%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, NGENF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CSLLY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, UCBJF has a market cap of 64.3B. Regarding current trading prices, NGENF is priced at $4.29, while UCBJF trades at $340.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas UCBJF's P/E ratio is 41.50. In terms of profitability, NGENF's ROE is -974.60%, compared to UCBJF's ROE of +0.14%. Regarding short-term risk, NGENF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check UCBJF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, UCBJY has a market cap of 62B. Regarding current trading prices, NGENF is priced at $4.29, while UCBJY trades at $159.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas UCBJY's P/E ratio is 40.08. In terms of profitability, NGENF's ROE is -974.60%, compared to UCBJY's ROE of +0.14%. Regarding short-term risk, NGENF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check UCBJY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CMXHF has a market cap of 50.7B. Regarding current trading prices, NGENF is priced at $4.29, while CMXHF trades at $103.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CMXHF's P/E ratio is 16.95. In terms of profitability, NGENF's ROE is -974.60%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, NGENF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CMXHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, NGENF is priced at $4.29, while ARGNF trades at $814.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ARGNF's P/E ratio is 34.81. In terms of profitability, NGENF's ROE is -974.60%, compared to ARGNF's ROE of +0.22%. Regarding short-term risk, NGENF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ARGNF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, NGENF is priced at $4.29, while WXIBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas WXIBF's P/E ratio is 37.50. In terms of profitability, NGENF's ROE is -974.60%, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, NGENF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check WXIBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, WXXWY has a market cap of 21.4B. Regarding current trading prices, NGENF is priced at $4.29, while WXXWY trades at $10.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas WXXWY's P/E ratio is 37.63. In terms of profitability, NGENF's ROE is -974.60%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, NGENF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check WXXWY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, IVBXF has a market cap of 19.8B. Regarding current trading prices, NGENF is priced at $4.29, while IVBXF trades at $11.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas IVBXF's P/E ratio is 115.00. In terms of profitability, NGENF's ROE is -974.60%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, NGENF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IVBXF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GNMSF has a market cap of 17.5B. Regarding current trading prices, NGENF is priced at $4.29, while GNMSF trades at $284.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GNMSF's P/E ratio is 12.46. In terms of profitability, NGENF's ROE is -974.60%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, NGENF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNMSF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SBMFF has a market cap of 15B. Regarding current trading prices, NGENF is priced at $4.29, while SBMFF trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SBMFF's P/E ratio is 28.00. In terms of profitability, NGENF's ROE is -974.60%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, NGENF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SBMFF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, NGENF is priced at $4.29, while SBHMY trades at $15.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SBHMY's P/E ratio is 25.63. In terms of profitability, NGENF's ROE is -974.60%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, NGENF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SBHMY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, AAVXF has a market cap of 9.9B. Regarding current trading prices, NGENF is priced at $4.29, while AAVXF trades at $125.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas AAVXF's P/E ratio is -24.03. In terms of profitability, NGENF's ROE is -974.60%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, NGENF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AAVXF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, NGENF is priced at $4.29, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BRRGF's P/E ratio is -47.60. In terms of profitability, NGENF's ROE is -974.60%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, NGENF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BRRGF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, NGENF is priced at $4.29, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ODTC's P/E ratio is 1.07. In terms of profitability, NGENF's ROE is -974.60%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, NGENF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ODTC's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, NGENF is priced at $4.29, while AKBLF trades at $36.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas AKBLF's P/E ratio is 45.70. In terms of profitability, NGENF's ROE is -974.60%, compared to AKBLF's ROE of +0.19%. Regarding short-term risk, NGENF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AKBLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, NGENF is priced at $4.29, while TRSBF trades at $2.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas TRSBF's P/E ratio is 18.71. In terms of profitability, NGENF's ROE is -974.60%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, NGENF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TRSBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, NGENF is priced at $4.29, while REGMF trades at $9.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas REGMF's P/E ratio is -31.65. In terms of profitability, NGENF's ROE is -974.60%, compared to REGMF's ROE of -0.45%. Regarding short-term risk, NGENF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check REGMF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, NGENF is priced at $4.29, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, NGENF's ROE is -974.60%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, NGENF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ABCZF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, NGENF is priced at $4.29, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas LABFF's P/E ratio is 28.95. In terms of profitability, NGENF's ROE is -974.60%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, NGENF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check LABFF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, NGENF is priced at $4.29, while ZLDPF trades at $60.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ZLDPF's P/E ratio is 4.18. In terms of profitability, NGENF's ROE is -974.60%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, NGENF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ZLDPF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SHJBF has a market cap of 4.1B. Regarding current trading prices, NGENF is priced at $4.29, while SHJBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SHJBF's P/E ratio is -20.00. In terms of profitability, NGENF's ROE is -974.60%, compared to SHJBF's ROE of -0.16%. Regarding short-term risk, NGENF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SHJBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, NGENF is priced at $4.29, while GNNSF trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GNNSF's P/E ratio is -43.75. In terms of profitability, NGENF's ROE is -974.60%, compared to GNNSF's ROE of +0.71%. Regarding short-term risk, NGENF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check GNNSF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, NGENF is priced at $4.29, while CAMRF trades at $58.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CAMRF's P/E ratio is 40.00. In terms of profitability, NGENF's ROE is -974.60%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, NGENF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CAMRF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, NGENF is priced at $4.29, while BRCTF trades at $38.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BRCTF's P/E ratio is 30.16. In terms of profitability, NGENF's ROE is -974.60%, compared to BRCTF's ROE of +0.59%. Regarding short-term risk, NGENF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BRCTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, NGENF is priced at $4.29, while ASPHF trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ASPHF's P/E ratio is -16.31. In terms of profitability, NGENF's ROE is -974.60%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, NGENF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ASPHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, NGENF is priced at $4.29, while INCPF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas INCPF's P/E ratio is -102.50. In terms of profitability, NGENF's ROE is -974.60%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, NGENF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check INCPF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, NGENF is priced at $4.29, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, NGENF's ROE is -974.60%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, NGENF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MPSYF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, TLPPF has a market cap of 2.6B. Regarding current trading prices, NGENF is priced at $4.29, while TLPPF trades at $6.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas TLPPF's P/E ratio is 384.50. In terms of profitability, NGENF's ROE is -974.60%, compared to TLPPF's ROE of +0.07%. Regarding short-term risk, NGENF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check TLPPF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GENSF has a market cap of 2.5B. Regarding current trading prices, NGENF is priced at $4.29, while GENSF trades at $37.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GENSF's P/E ratio is 95.51. In terms of profitability, NGENF's ROE is -974.60%, compared to GENSF's ROE of +0.04%. Regarding short-term risk, NGENF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GENSF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, NGENF is priced at $4.29, while BVNRY trades at $10.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BVNRY's P/E ratio is 6.33. In terms of profitability, NGENF's ROE is -974.60%, compared to BVNRY's ROE of +0.20%. Regarding short-term risk, NGENF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BVNRY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, NGENF is priced at $4.29, while BVNKF trades at $30.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BVNKF's P/E ratio is 6.24. In terms of profitability, NGENF's ROE is -974.60%, compared to BVNKF's ROE of +0.20%. Regarding short-term risk, NGENF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BVNKF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, NGENF is priced at $4.29, while GLPGF trades at $34.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GLPGF's P/E ratio is -4.24. In terms of profitability, NGENF's ROE is -974.60%, compared to GLPGF's ROE of -0.16%. Regarding short-term risk, NGENF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GLPGF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, NGENF is priced at $4.29, while ASCLF trades at $2.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ASCLF's P/E ratio is -56.37. In terms of profitability, NGENF's ROE is -974.60%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, NGENF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check ASCLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, NGENF is priced at $4.29, while MEOBF trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas MEOBF's P/E ratio is -15.90. In terms of profitability, NGENF's ROE is -974.60%, compared to MEOBF's ROE of -0.19%. Regarding short-term risk, NGENF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check MEOBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ONTTF has a market cap of 1.9B. Regarding current trading prices, NGENF is priced at $4.29, while ONTTF trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ONTTF's P/E ratio is -9.80. In terms of profitability, NGENF's ROE is -974.60%, compared to ONTTF's ROE of -0.26%. Regarding short-term risk, NGENF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ONTTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, NGENF is priced at $4.29, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BIESF's P/E ratio is -44.44. In terms of profitability, NGENF's ROE is -974.60%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, NGENF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BIESF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PHMMF has a market cap of 1.5B. Regarding current trading prices, NGENF is priced at $4.29, while PHMMF trades at $88.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PHMMF's P/E ratio is 38.57. In terms of profitability, NGENF's ROE is -974.60%, compared to PHMMF's ROE of +0.17%. Regarding short-term risk, NGENF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PHMMF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $4.29, while HBMHF trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, NGENF's ROE is -974.60%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, NGENF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HBMHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $4.29, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, NGENF's ROE is -974.60%, compared to SNBIF's ROE of -2.53%. Regarding short-term risk, NGENF is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SNBIF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, IDRSF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $4.29, while IDRSF trades at $5.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas IDRSF's P/E ratio is -6.42. In terms of profitability, NGENF's ROE is -974.60%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, NGENF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IDRSF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $4.29, while CSBTF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CSBTF's P/E ratio is -160.00. In terms of profitability, NGENF's ROE is -974.60%, compared to CSBTF's ROE of -0.08%. Regarding short-term risk, NGENF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CSBTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, NURPF has a market cap of 1.2B. Regarding current trading prices, NGENF is priced at $4.29, while NURPF trades at $8.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas NURPF's P/E ratio is 12.32. In terms of profitability, NGENF's ROE is -974.60%, compared to NURPF's ROE of +0.43%. Regarding short-term risk, NGENF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NURPF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, NGENF is priced at $4.29, while CSPHF trades at $0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CSPHF's P/E ratio is -20.01. In terms of profitability, NGENF's ROE is -974.60%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, NGENF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CSPHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, NGENF is priced at $4.29, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, NGENF's ROE is -974.60%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, NGENF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MDCLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, NGENF is priced at $4.29, while PPTDF trades at $9.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PPTDF's P/E ratio is -35.40. In terms of profitability, NGENF's ROE is -974.60%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, NGENF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PPTDF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, NGENF is priced at $4.29, while PHGUF trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PHGUF's P/E ratio is -160.00. In terms of profitability, NGENF's ROE is -974.60%, compared to PHGUF's ROE of +0.00%. Regarding short-term risk, NGENF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PHGUF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, NGENF is priced at $4.29, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, NGENF's ROE is -974.60%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, NGENF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BTTAY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, NGENF is priced at $4.29, while TKBIF trades at $5.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas TKBIF's P/E ratio is -20.86. In terms of profitability, NGENF's ROE is -974.60%, compared to TKBIF's ROE of N/A. Regarding short-term risk, NGENF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TKBIF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, NGENF is priced at $4.29, while BPMUF trades at $71.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, NGENF's ROE is -974.60%, compared to BPMUF's ROE of +0.44%. Regarding short-term risk, NGENF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BPMUF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, INRLF has a market cap of 833.8M. Regarding current trading prices, NGENF is priced at $4.29, while INRLF trades at $4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas INRLF's P/E ratio is -6.29. In terms of profitability, NGENF's ROE is -974.60%, compared to INRLF's ROE of -0.59%. Regarding short-term risk, NGENF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check INRLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, NGENF is priced at $4.29, while VBIZF trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, NGENF's ROE is -974.60%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, NGENF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check VBIZF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, NGENF is priced at $4.29, while IVEVF trades at $4.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, NGENF's ROE is -974.60%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, NGENF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check IVEVF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, NGENF is priced at $4.29, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, NGENF's ROE is -974.60%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, NGENF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CKDXF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SOLTF has a market cap of 492.3M. Regarding current trading prices, NGENF is priced at $4.29, while SOLTF trades at $5.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SOLTF's P/E ratio is -23.65. In terms of profitability, NGENF's ROE is -974.60%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, NGENF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SOLTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GNFTF has a market cap of 461M. Regarding current trading prices, NGENF is priced at $4.29, while GNFTF trades at $9.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GNFTF's P/E ratio is -9.95. In terms of profitability, NGENF's ROE is -974.60%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, NGENF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNFTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, NGENF is priced at $4.29, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas RAONF's P/E ratio is -43.33. In terms of profitability, NGENF's ROE is -974.60%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, NGENF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check RAONF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, NGENF is priced at $4.29, while GNFTY trades at $8.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas GNFTY's P/E ratio is -9.62. In terms of profitability, NGENF's ROE is -974.60%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, NGENF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check GNFTY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, NGENF is priced at $4.29, while BOVNF trades at $6.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, NGENF's ROE is -974.60%, compared to BOVNF's ROE of -0.41%. Regarding short-term risk, NGENF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BOVNF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, NGENF is priced at $4.29, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, NGENF's ROE is -974.60%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, NGENF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TBGNF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, NGENF is priced at $4.29, while CLVLF trades at $8.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, NGENF's ROE is -974.60%, compared to CLVLF's ROE of +0.16%. Regarding short-term risk, NGENF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CLVLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CLVLY has a market cap of 416.7M. Regarding current trading prices, NGENF is priced at $4.29, while CLVLY trades at $8.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CLVLY's P/E ratio is 16.27. In terms of profitability, NGENF's ROE is -974.60%, compared to CLVLY's ROE of +0.16%. Regarding short-term risk, NGENF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CLVLY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PTCHF has a market cap of 410.4M. Regarding current trading prices, NGENF is priced at $4.29, while PTCHF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PTCHF's P/E ratio is 9.99. In terms of profitability, NGENF's ROE is -974.60%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, NGENF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PTCHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, NWBO has a market cap of 369.9M. Regarding current trading prices, NGENF is priced at $4.29, while NWBO trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas NWBO's P/E ratio is -4.00. In terms of profitability, NGENF's ROE is -974.60%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, NGENF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NWBO's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PRRUF has a market cap of 368M. Regarding current trading prices, NGENF is priced at $4.29, while PRRUF trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PRRUF's P/E ratio is -8.33. In terms of profitability, NGENF's ROE is -974.60%, compared to PRRUF's ROE of -0.27%. Regarding short-term risk, NGENF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PRRUF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, AVCTF has a market cap of 349.9M. Regarding current trading prices, NGENF is priced at $4.29, while AVCTF trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas AVCTF's P/E ratio is -5.33. In terms of profitability, NGENF's ROE is -974.60%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, NGENF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AVCTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CYDY has a market cap of 326.7M. Regarding current trading prices, NGENF is priced at $4.29, while CYDY trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CYDY's P/E ratio is -8.57. In terms of profitability, NGENF's ROE is -974.60%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, NGENF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CYDY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, NGENF is priced at $4.29, while CMVLF trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, NGENF's ROE is -974.60%, compared to CMVLF's ROE of -0.32%. Regarding short-term risk, NGENF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CMVLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SPHDF has a market cap of 294.9M. Regarding current trading prices, NGENF is priced at $4.29, while SPHDF trades at $21.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SPHDF's P/E ratio is -3.03. In terms of profitability, NGENF's ROE is -974.60%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, NGENF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SPHDF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, NGENF is priced at $4.29, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, NGENF's ROE is -974.60%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, NGENF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PBBIF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, FGHQF has a market cap of 283.9M. Regarding current trading prices, NGENF is priced at $4.29, while FGHQF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas FGHQF's P/E ratio is 14.00. In terms of profitability, NGENF's ROE is -974.60%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, NGENF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check FGHQF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, NGENF is priced at $4.29, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, NGENF's ROE is -974.60%, compared to ORPOF's ROE of N/A. Regarding short-term risk, NGENF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ORPOF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, HNSBF has a market cap of 246.6M. Regarding current trading prices, NGENF is priced at $4.29, while HNSBF trades at $2.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas HNSBF's P/E ratio is -2.88. In terms of profitability, NGENF's ROE is -974.60%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, NGENF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HNSBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, HLOSF has a market cap of 243M. Regarding current trading prices, NGENF is priced at $4.29, while HLOSF trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas HLOSF's P/E ratio is -5.38. In terms of profitability, NGENF's ROE is -974.60%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, NGENF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HLOSF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, NGENF is priced at $4.29, while OPORF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas OPORF's P/E ratio is 35.00. In terms of profitability, NGENF's ROE is -974.60%, compared to OPORF's ROE of +0.12%. Regarding short-term risk, NGENF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check OPORF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, NGENF is priced at $4.29, while NWPHF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas NWPHF's P/E ratio is N/A. In terms of profitability, NGENF's ROE is -974.60%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, NGENF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NWPHF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ORYZF has a market cap of 238.9M. Regarding current trading prices, NGENF is priced at $4.29, while ORYZF trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, NGENF's ROE is -974.60%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, NGENF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ORYZF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, NGENF is priced at $4.29, while SLNCF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SLNCF's P/E ratio is -3.56. In terms of profitability, NGENF's ROE is -974.60%, compared to SLNCF's ROE of -1.32%. Regarding short-term risk, NGENF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SLNCF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, NGENF is priced at $4.29, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, NGENF's ROE is -974.60%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, NGENF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check FPHAF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, NGENF is priced at $4.29, while VSBC trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas VSBC's P/E ratio is N/A. In terms of profitability, NGENF's ROE is -974.60%, compared to VSBC's ROE of +10.17%. Regarding short-term risk, NGENF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check VSBC's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SCNLF has a market cap of 200.1M. Regarding current trading prices, NGENF is priced at $4.29, while SCNLF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SCNLF's P/E ratio is -19.28. In terms of profitability, NGENF's ROE is -974.60%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, NGENF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check SCNLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, IPHYF has a market cap of 186.5M. Regarding current trading prices, NGENF is priced at $4.29, while IPHYF trades at $1.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas IPHYF's P/E ratio is -3.06. In terms of profitability, NGENF's ROE is -974.60%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, NGENF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IPHYF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, KNTPF has a market cap of 184M. Regarding current trading prices, NGENF is priced at $4.29, while KNTPF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas KNTPF's P/E ratio is -6.54. In terms of profitability, NGENF's ROE is -974.60%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, NGENF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check KNTPF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BBIXF has a market cap of 175.2M. Regarding current trading prices, NGENF is priced at $4.29, while BBIXF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BBIXF's P/E ratio is -15.00. In terms of profitability, NGENF's ROE is -974.60%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, NGENF is more volatile compared to BBIXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BBIXF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, MSCLF has a market cap of 174.1M. Regarding current trading prices, NGENF is priced at $4.29, while MSCLF trades at $11.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas MSCLF's P/E ratio is 4.38. In terms of profitability, NGENF's ROE is -974.60%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, NGENF is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MSCLF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, RECEF has a market cap of 174M. Regarding current trading prices, NGENF is priced at $4.29, while RECEF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas RECEF's P/E ratio is -8.33. In terms of profitability, NGENF's ROE is -974.60%, compared to RECEF's ROE of +5.33%. Regarding short-term risk, NGENF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check RECEF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, NGENF is priced at $4.29, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, NGENF's ROE is -974.60%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, NGENF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ADOCY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, SPHRY has a market cap of 150.3M. Regarding current trading prices, NGENF is priced at $4.29, while SPHRY trades at $3.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas SPHRY's P/E ratio is -59.67. In terms of profitability, NGENF's ROE is -974.60%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, NGENF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SPHRY's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, NGENF is priced at $4.29, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, NGENF's ROE is -974.60%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, NGENF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AMGXF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, NGENF is priced at $4.29, while BRIBF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas BRIBF's P/E ratio is -2.69. In terms of profitability, NGENF's ROE is -974.60%, compared to BRIBF's ROE of -0.07%. Regarding short-term risk, NGENF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BRIBF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, NGENF is priced at $4.29, while HBPCF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, NGENF's ROE is -974.60%, compared to HBPCF's ROE of -0.65%. Regarding short-term risk, NGENF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HBPCF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, NGENF is priced at $4.29, while TRGNF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, NGENF's ROE is -974.60%, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, NGENF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check TRGNF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, MLLCF has a market cap of 130.9M. Regarding current trading prices, NGENF is priced at $4.29, while MLLCF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas MLLCF's P/E ratio is -1.67. In terms of profitability, NGENF's ROE is -974.60%, compared to MLLCF's ROE of -0.51%. Regarding short-term risk, NGENF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MLLCF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, NGENF is priced at $4.29, while JWCTF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas JWCTF's P/E ratio is -1.46. In terms of profitability, NGENF's ROE is -974.60%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, NGENF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check JWCTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, NGENF is priced at $4.29, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas AAPGV's P/E ratio is N/A. In terms of profitability, NGENF's ROE is -974.60%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, NGENF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check AAPGV's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, NGENF is priced at $4.29, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, NGENF's ROE is -974.60%, compared to PSTTF's ROE of N/A. Regarding short-term risk, NGENF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PSTTF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, NDTP has a market cap of 113.6M. Regarding current trading prices, NGENF is priced at $4.29, while NDTP trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas NDTP's P/E ratio is -2.22. In terms of profitability, NGENF's ROE is -974.60%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, NGENF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NDTP's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, PRNAF has a market cap of 109.8M. Regarding current trading prices, NGENF is priced at $4.29, while PRNAF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas PRNAF's P/E ratio is -1.01. In terms of profitability, NGENF's ROE is -974.60%, compared to PRNAF's ROE of -0.38%. Regarding short-term risk, NGENF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PRNAF's competition here

NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NGENF stands at 339.8M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, NGENF is priced at $4.29, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NGENF currently has a P/E ratio of -16.50, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, NGENF's ROE is -974.60%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, NGENF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check EPRXF's competition here